» Articles » PMID: 23632333

Surgery and Prognostic Factors of Patients with Epidural Spinal Cord Compression Caused by Hepatocellular Carcinoma Metastases: Retrospective Study of 36 Patients in a Single Center

Overview
Specialty Orthopedics
Date 2013 May 2
PMID 23632333
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Study Design: A retrospective study of 36 patients with metastatic hepatocellular carcinoma (HCC) of the mobile spine was performed by survival analysis.

Objective: To discuss the factors that may affect outcomes of patients with HCC spinal metastases.

Summary Of Background Data: HCC is a rare tumor in Western countries. However, HCC is common in Far East (Taiwan, Korea, mainland China), where the hepatitis B virus is epidemic. As the mean survival time of patients with HCC has largely increased in recent years, it is now more common to encounter a patient with epidural spinal cord compression caused by HCC spinal metastases in clinic.

Methods: The univariate and multivariate analyses of various clinical factors were performed to identify independent variables that could predict prognosis. The survival rate was estimated by the Kaplan-Meier method, and differences were analyzed by the log-rank test. Factors with P values of 0.1 or less were subjected to multivariate analysis for survival rate by multivariate Cox proportional hazards analysis.

Results: A total of 36 patients with metastatic HCC of the mobile spine were included in the study. Age (≤45 yr/>45 yr), duration of preoperative symptoms (<6 mo/≥6 mo), preoperative Frankel score (A-C/D-E), Tomita score (5-7/8-10), and bisphosphonate treatment were suggested as the potential prognostic factors through univariate analysis. However, as they were submitted to the multivariate Cox regression model, only Tomita score was found as an independent prognostic factor.

Conclusion: Tomita score no more than 7 is a favorable prognostic factor for HCC metastases in the mobile spine.

Level Of Evidence: 4.

Citing Articles

Surgical management and outcomes of spinal metastasis of malignant adrenal tumor: A retrospective study of six cases and literature review.

Ni X, Wang J, Cao J, Zhang K, Hou S, Huang X Front Oncol. 2023; 13:1110045.

PMID: 36776311 PMC: 9909542. DOI: 10.3389/fonc.2023.1110045.


Bone metastasis of hepatocellular carcinoma: facts and hopes from clinical and translational perspectives.

Huang Z, Wen J, Wang Y, Han S, Li Z, Hu X Front Med. 2022; 16(4):551-573.

PMID: 35852753 DOI: 10.1007/s11684-022-0928-z.


Natural disease progression and novel survival prediction model for hepatocellular carcinoma with spinal metastases: a 10-year single-center study.

Phinyo P, Boonyanaruthee C, Paholpak P, Pruksakorn D, Phanphaisarn A, Sangsin A World J Surg Oncol. 2020; 18(1):135.

PMID: 32563268 PMC: 7306143. DOI: 10.1186/s12957-020-01913-9.


En Bloc lumpectomy of T12 vertebra for progressive hepatocellular carcinoma metastases following liver transplantation: A case report.

Hu J, Lu Y, Lin X Medicine (Baltimore). 2020; 99(2):e18756.

PMID: 31914098 PMC: 6959957. DOI: 10.1097/MD.0000000000018756.


Classification and scoring systems for metastatic spine tumors: a literature review.

Tokuhashi Y, Uei H, Oshima M Spine Surg Relat Res. 2019; 1(2):44-55.

PMID: 31440612 PMC: 6698555. DOI: 10.22603/ssrr.1.2016-0021.